EFFECTS OF AGE, SEX STEROIDS, AND FAMILY RELATIONSHIPS ON VOLUMES OF PROSTATE ZONES IN MEN WITH AND WITHOUT PROSTATE-CANCER

被引:21
|
作者
MEIKLE, AW
STEPHENSON, RA
MCWHORTER, WP
SKOLNICK, MH
MIDDLETON, RG
机构
[1] UNIV UTAH,SCH MED,DEPT UROL,SALT LAKE CITY,UT 84132
[2] UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT 84132
来源
PROSTATE | 1995年 / 26卷 / 05期
关键词
D O I
10.1002/pros.2990260505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Benign prostatic hyperplasia (BPH) and prostate cancer commonly occur together. This suggests that common familial, hormonal, and environmental factors contribute to their development. In men at risk for the development of prostate cancer (at 40 men in 19 families) and aged-matched unrelated controls (n = 46), we have determined whether familial factors, age, and blood hormone concentrations are related to the transition zone (TZ), peripheral zone (PZ), or total volume of the prostate measured by transrectal ultrasound (TRUS). We determined that the influences of age, prostate cancer (n = 15), and familial status did not significantly affect the relationships reported. Therefore, data from all groups were combined for this study. TZ correlated positively with age (P = 0.003) after controlling for family status, but total prostate volume correlated insignificantly with age (P = 0.08). In addition, the ratio of TZ to PZ volumes also correlated significantly with age in the control group (r = 0.27, P = 0.014). Both TZ and PZ volumes correlated highly(r = 0.91, P < 0.0001, n = 86) with total volume. In addition, total volume correlated significantly (r = 0.71, P < 0.001) with the ratio of the TZ/PZ volumes, which also correlated significantly with each other (r = 0.61, P < 0.0001, n = 86). In contrast to the increase of TZ volume related to total prostate volume, PZ volume declined compared with total volume. Prostate volumes up to 50 mi are predominated by the PZ and above 50 mi by the TZ, which may compress and shrink the PZ. Both TZ and total prostate volume correlated positively with serum estrone concentrations (P = 0.04 and P = 0.003, respectively). These results suggest that the risk of prostate cancer does not contribute to generalized overgrowth of the prostate, including the TZ. However, estrogens and age strongly influence TZ but not PZ volume. Both PZ and TZ volumes rise together until the prostate exceeds 50 mi, when the growth of the TZ appears to exceed the PZ and then to compress it. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 50 条
  • [1] PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN WITH AND WITHOUT PROSTATE-CANCER
    CHEN, IW
    KAPLAN, LA
    SPERLING, MI
    HEMINGER, LA
    MAXON, HR
    BRACKEN, RB
    [J]. JOURNAL OF UROLOGY, 1987, 137 (04): : A360 - A360
  • [2] PROSTATE-CANCER DETECTION BY PROSTATE-SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION IN MEN WITH FAMILY HISTORIES OF PROSTATE-CANCER
    GIRARDI, SK
    LUBIN, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 1489 - 1489
  • [3] BODY DIMENSION DIFFERENCES IN MEN WITH OR WITHOUT PROSTATE-CANCER
    DEMARKWAHNEFRIED, W
    PAULSON, DF
    ROBERTSON, CN
    ANDERSON, EE
    CONAWAY, MR
    RIMER, BK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (17) : 1363 - 1364
  • [4] PATTERNS OF CARE RELATED TO AGE OF MEN WITH PROSTATE-CANCER
    BENNETT, CL
    GREENFIELD, S
    ARONOW, H
    GANZ, P
    VOGELZANG, NJ
    ELASHOFF, RM
    [J]. CANCER, 1991, 67 (10) : 2633 - 2641
  • [5] DESIGN OF CYTOTOXIC STEROIDS FOR PROSTATE-CANCER
    PETROW, V
    PADILLA, GM
    [J]. PROSTATE, 1986, 9 (02): : 169 - 182
  • [6] THE DISTRIBUTION OF PROSTATE SPECIFIC ANTIGEN IN MEN WITHOUT CLINICAL OR PATHOLOGICAL EVIDENCE OF PROSTATE-CANCER - RELATIONSHIP TO GLAND VOLUME AND AGE
    BABAIAN, RJ
    MIYASHITA, H
    EVANS, RB
    RAMIREZ, EI
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03): : 837 - 840
  • [7] AGE AND SURVIVAL IN PROSTATE-CANCER
    TOTONCHI, E
    WANG, E
    RAY, P
    ABROMOWITZ, J
    MCKIEL, C
    GUINAN, P
    [J]. CLINICAL RESEARCH, 1984, 32 (05): : A854 - A854
  • [8] LONGITUDINAL EVALUATION OF SERUM ANDROGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE-CANCER
    CARTER, HB
    PEARSON, JD
    METTER, EJ
    CHAN, DW
    ANDRES, R
    FOZARD, JL
    ROSNER, W
    WALSH, PC
    [J]. PROSTATE, 1995, 27 (01): : 25 - 31
  • [9] ANDROGEN SUPPRESSION BY HYDROCORTISONE WITHOUT AMINOGLUTETHIMIDE IN ORCHIECTOMIZED MEN WITH PROSTATE-CANCER
    PERRY, LA
    PLOWMAN, PN
    ROWELL, NP
    CHARD, T
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 736 - 736
  • [10] FAMILY HISTORY AND THE RISK OF PROSTATE-CANCER
    STEINBERG, GD
    CARTER, BS
    BEATY, TH
    CHILDS, B
    WALSH, PC
    [J]. PROSTATE, 1990, 17 (04): : 337 - 347